A New Drug Slows Alzheimer’s By One-Third (M)

Patients were also 40 percent less likely to progress from mild cognitive impairment to full-blown dementia after taking the drug.

Patients were also 40 percent less likely to progress from mild cognitive impairment to full-blown dementia after taking the drug.

Keep reading with a membership

• Adverts removed
• Cancel at any time
• 14 day money-back guarantee

Join PsyBlog

Members can sign in below:

Author: Jeremy Dean

Psychologist, Jeremy Dean, PhD is the founder and author of PsyBlog. He holds a doctorate in psychology from University College London and two other advanced degrees in psychology. He has been writing about scientific research on PsyBlog since 2004. He is also the author of the book "Making Habits, Breaking Habits" (Da Capo, 2013) and several ebooks.